Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoids vs Placebo for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
NCT05674994Phase 3Recruiting
- Sponsor
- Fondation Hôpital Saint-Joseph
- Start
- Oct 2023
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone injection, prednisone in acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF), sponsored by Fondation Hôpital Saint-Joseph. Started Oct 2023; status: recruiting.
02
Drugs
methylprednisolone injectionprednisone
03
Conditions
acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF)
Beyond the preview
Go deeper on NCT05674994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05674994.